Showing results 1 to 32 of 32
|A prospective study on the added value of pulsed arterial spin-labeling and apparent diffusion coefficients in the grading of gliomas.
|Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation.
|Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation.
|Clinical experience of glioma surgery using "tailed bullet": overcoming the limitations of conventional neuro-navigation guided surgery.
|Combination of high-resolution susceptibility-weighted imaging and the apparent diffusion coefficient: added value to brain tumour imaging and clinical feasibility of non-contrast MRI at 3 T.
|Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study)
|Development of Biodegradable Polymer Releasing Anticancer Drug for Intratumoral Chemotherapy of Brain Tumor-in Vitro Results
|Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas
|김성수, 서해영, 장다영
|Dosimetric Effects of Magnetic Resonance Imaging-assisted Radiotherapy Planning: Dose Optimization for Target Volumes at High Risk and Analytic Radiobiological Dose Evaluation.
|Epigenetic downregulation of STAT6 increases HIF-1alpha expression via mTOR/S6K/S6, leading to enhanced hypoxic viability of glioma cells
|김세혁, 김현미, 박수정, 조은혜, 주일로
|Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma
|Induction of radioprotective peroxiredoxin-I by ionizing irradiation.
|Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study)
|Interferon regulatory factor 7 regulates glioma stem cells via interleukin-6 and Notch signalling
|Mobile Phone Use and Time Trend of Brain Cancer Incidence Rate in Korea
|Monensin, a polyether ionophore antibiotic, overcomes TRAIL resistance in glioma cells via endoplasmic reticulum stress, DR5 upregulation and c-FLIP downregulation.
|Paxilline enhances TRAIL-mediated apoptosis of glioma cells via modulation of c-FLIP, survivin and DR5.
|Predicting survival using the 2016 World Health Organization classification for anaplastic glioma
|Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas.
|Proteome-wide discovery of mislocated proteins in cancer.
|Quercetin and chloroquine synergistically induces cell death in glioma cells via the increase of Ca2+ and ROS levels
|Radiation-induced autophagy contributes to cell death and induces apoptosis partly in malignant glioma cells.
|Romo1 is associated with ROS production and cellular growth in human gliomas.
|Rottlerin sensitizes glioma cells to TRAIL-induced apoptosis by inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP.
|Salinomycin induces endoplasmic reticulum stressmediated autophagy and apoptosis through generation of reactive oxygen species in human glioma U87MG cells
|Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin.
|Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP.
|Sodium selenite induces superoxide-mediated mitochondrial damage and subsequent autophagic cell death in malignant glioma cells.
|Stereological analysis on migration of human neural stem cells in the brain of rats bearing glioma.
|TIMP-1 modulates chemotaxis of human neural stem cells through CD63 and integrin signalling.
|Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma
|β-Lapachone-induced reactive oxygen species (ROS) generation mediates autophagic cell death in glioma U87 MG cells.